Survivin overexpression is associated with poor prognosis of human gastric cancer and is a target for gastric cancer therapy. cancer cells. YM155 infusion NHS-Biotin at 5 mg/kg/day for 7 days markedly inhibited growth of gastric cancer xenograft in a nude mouse model. Immunohistochemistry staining and Western Blot showed that YM155 treatment inhibited expression of survivin… Continue reading Survivin overexpression is associated with poor prognosis of human gastric cancer